APA (7th ed.) Citation

B, R., B, R., JA, G., 3rd, B. H., S, L., A, F., . . . JR, I. (2014). A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 25(9), 1794. https://doi.org/10.1093/annonc/mdu212

Chicago Style (17th ed.) Citation

B, Rini, Redman B, Garcia JA, Burris HA 3rd, Li S, Fandi A, Beck R, Jungnelius U, and Infante JR. "A Phase I/II Study of Lenalidomide in Combination with Sunitinib in Patients with Advanced or Metastatic Renal Cell Carcinoma." Annals of Oncology : Official Journal of the European Society for Medical Oncology 25, no. 9 (2014): 1794. https://doi.org/10.1093/annonc/mdu212.

MLA (9th ed.) Citation

B, Rini, et al. "A Phase I/II Study of Lenalidomide in Combination with Sunitinib in Patients with Advanced or Metastatic Renal Cell Carcinoma." Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 25, no. 9, 2014, p. 1794, https://doi.org/10.1093/annonc/mdu212.